November 13th. Transenterix Inc announced that the company has sold a Senhance robot to Florida Hospital. Florida Hospital is a member of Adventist Health System, which operates 45 hospitals in 9 states, making it one of the largest not-for-profit healthcare systems in the United States, caring for more than 5 million patients annually.
November 11th 2017. We are withdrawing our recommendation on Array Biopharma. Please see or ARTICLES section for financial results of the recommendation. Congratulations to all the long term investors who have been following the stock over 1 year period. We are looking forward to publishing a new long term free recommendation in the coming days. Keep checking our site.
November 9th. Transenterix announced financial results and business update for Q3 2017
-The Senhahce robot has been approved by FDA for commercial sales in the U.S
-1 robot sold in Taiwan in Q3 2017
-Commercial infrastructure built in the U.S. - 17 sales representatives in place.
-1 sales pending (pre order issued) in EU - to be booked in Q4
-At least 1 sale expected in the U.S. in Q4
-$100 M cash in bank - enough to keep the company running well beyond 2018